MedPath

Clinical Safety Trial of Long-Term Intermittent Use of Helioblock® SX Cream

Phase 3
Completed
Conditions
Sunburn
Registration Number
NCT00326274
Lead Sponsor
Loreal USA
Brief Summary

The purpose of this study is to determine the safety potential of Helioblock® SX Cream as a sunscreen product in long term intermittent use conditions among pediatric subjects.. Each subject will be enrolled to participate for six months. The test product should be applied every day that outdoor activities are planned, prior to any significant sun exposure during out-door activities (such as the beach, outdoor sport activities), or whenever the subject needs to be protected against sunburn or other damage due to the sun. A minimum of 14 days test product use and sun exposure is required.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Male or female subjects of any race or skin type, 6 months to 12 years of age inclusive, willing to use the test product intermittently for six months during outside activities
Exclusion Criteria
  • Subjects with known sensitivities to any of the study ingredients or subjects with a condition or in a situation, which in the Investigator's opinion, may suggest a significant hazard for the subject, may confound the study results, or interfere with the subject's participation in the study.
  • Subjects who are pregnant or lactating

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Long term safety after 6 months intermittent use in a pediatric population6 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Research Testing Laboratories

🇺🇸

Great Neck, New York, United States

© Copyright 2025. All Rights Reserved by MedPath